VytronUS Inc Raises 49 Million in Series C Financing

Friday, July 29, 2016 PR Newswire

SUNNYVALE Calif July 29 2016 PRNewswire VytronUS Inc VytronUS a privately held medical device company developing novel technologies for the treatment of cardiac arrhythmias announced today that it has secured49 millionin Series C equity financing The current syndicate of investors enthusiastically..

China Cord Blood Corporation Files Its Annual Report on Form 20F

Thursday, July 28, 2016 PR Newswire

HONG KONG July 28 2016 PRNewswire China Cord Blood Corporation NYSE CO CCBC or the Company Chinas leading provider of cord blood collection laboratory testing hematopoietic stem cell processing and stem cell storage services today announced that the Company filed its Annual Report on Form 20F wit..

Teligent Inc Announces Second Quarter 2016 Results

Thursday, July 28, 2016 PR Newswire

BUENA NJ July 28 2016 PRNewswire Teligent Inc NASDAQ TLGT a New Jerseybased specialty generic pharmaceutical company today announced its financial results for the second quarter ended June 30 2016 Second Quarter 2016 Highlights Total revenues of 171 million in the second quarter of 2016 an in..

Valeant Pharmaceuticals Announces The Addition Of Sarah B Kavanagh To Its Board Of Directors

Thursday, July 28, 2016 PR Newswire

LAVAL Quebec July 28 2016 PRNewswire Valeant Pharmaceuticals International Inc NYSE VRX and TSX VRX today announced that the Board of Directors has appointed Ms Sarah B Kavanagh to serve as a director of the Board effective July 22 2016 With these changes Valeant has increased the size of its boar..

AbbVie Announces Initiation of Phase 3 Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma

Thursday, July 28, 2016 PR Newswire

NORTH CHICAGO Ill July 28 2016 PRNewswire AbbVie NYSE ABBV a global biopharmaceutical company today announced the initiation of a Phase 3 clinical trial to study the safety and efficacy of venetoclax in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple..

BERG Promotes Coveney To Vice President Of Finance And Controller

Thursday, July 28, 2016 PR Newswire

BOSTON July 28 2016 PRNewswire BERG a biopharmaceutical company uncovering health solutions through a datadriven biological research approach today announced the promotion of the companys Financial Controller Kevin Coveney to the position of Vice President of Finance and Controller upon the depart..

Natera Announces Second Quarter Earnings Conference Call

Thursday, July 28, 2016 PR Newswire

SAN CARLOS Calif July 28 2016 PRNewswire Natera Inc NASDAQ NTRA a leader in noninvasive genetic testing and the analysis of circulating cellfree DNA today announced that it will release results for its second quarter ended June 30 2016 after the market close on August 4 2016 Natera will host a co..

Protagonist Therapeutics Receives SBIR Funding for the Development of Injectable Hepcidin Mimetics for Treatment of Iron Overload Disorders

Thursday, July 28, 2016 PR Newswire

MILPITAS Calif July 28 2016 PRNewswire Protagonist Therapeutics Inc today announced receipt of a Phase 1 Small Business Innovation Research SBIR Grant from the National Institute of Heart and Lung Diseases of the National Institutes of Health The award Number HL13270201A1 supports preclinical res..

FDA Clears Expanded Indication for Itamar Medicals WatchPAT Sleep Apnea Diagnostic Device for Adolescents

Thursday, July 28, 2016 PR Newswire

CAESAREA Israel July 28 2016 PRNewswire Itamar Medical TASEITMR which develops and markets noninvasive diagnostic medical devices for sleeprelated breathing disorders received FDA clearance to expand the medical indication of WatchPAT for sleep apnea diagnosis Under this approval the use of Watc..

DarioHealth is Now DirecttoConsumer in Australia

Thursday, July 28, 2016 PR Newswire

BOSTON July 28 2016 PRNewswire DarioHealth Corp NASDAQDRIO a leader in digital health and mobile health solutions and the developer of the DarioTM Smart Diabetes Management Solution today announced that it has begun offering the Dario Smart Diabetes Management Solution direct to the consumer in ..

Aytu BioScience Inc Announces Common Stock Purchase Agreement for up to 105 Million

Thursday, July 28, 2016 PR Newswire

ENGLEWOOD Colo July 28 2016 PRNewswire Aytu BioScience Inc OTCQX AYTU Aytu a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology announced today that it has entered into a 105 million common stock purchase agreement with Lincoln Park Capit..

FDA approves Adlyxin to treat type 2 diabetes

Thursday, July 28, 2016 PR Newswire

SILVER SPRING Md July 28 2016 PRNewswireUSNewswire The US Food and Drug Administration approved Adlyxin lixisenatide a oncedaily injection to improve glycemic control blood sugar levels along with diet and exercise in adults with type 2 diabetes The FDA continues to support the development of n..

Oramed Reports Additional Phase IIb Oral Insulin Study Data Demonstrating Significant Lowering of Glucose Levels vs Placebo

Thursday, July 28, 2016 PR Newswire

JERUSALEM July 28 2016 PRNewswire Statistically Significant Results Across Key Glycemic Endpoints Conference Call Today at 1100 AM ET Oramed Pharmaceuticals Inc NASDAQ ORMP httpwwworamedcom a developer of oral drug delivery systems today reported additional data from the recently concluded..

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and YeartoDate 2016 Financial Results

Thursday, July 28, 2016 PR Newswire

BAUDETTE Minn July 28 2016 PRNewswire ANI Pharmaceuticals Inc NASDAQ ANIP announced today that the Company plans to release its second quarter and yeartodate 2016 financial results on Thursday August 4 2016 before the opening of the US financial markets The earnings press release will be accessib..

International Partnership Established to Tackle Antimicrobial Resistance

Thursday, July 28, 2016 PR Newswire

LONDON and WASHINGTON July 28 2016 PRNewswireUSNewswire The US Department of Health and Human Services HHS the Wellcome Trust of London the AMR Centre of Alderley Park Cheshire in the United Kingdom and Boston University School of Law today announced the establishment of one of the worlds largest..

BioHiTech Global Announces Partnership with Top Strategic Political Regulatory and Communications Consulting Firm Tusk Ventures

Thursday, July 28, 2016 PR Newswire

CHESTNUT RIDGE NY July 28 2016 PRNewswire BioHiTech Global Inc BioHiTech OTCQB BHTG a green technology company that provides innovative datadriven solutions for food waste disposal has partnered with Tusk Ventures the nations premier political regulatory and communications consulting firm Under th..

Leading Medical Physics Meeting to Feature 40 Presentations on ViewRays MRIdian System

Thursday, July 28, 2016 PR Newswire

CLEVELAND July 28 2016 PRNewswire ViewRay Inc Nasdaq VRAY makers of the worlds first and only clinical MRIguided radiation therapy systemannounced today that the companysMRIdian System is the focus of 40 abstracts selected by the American Association of Physicists in Medicine AAPM for presentatio..

Rubicon Genomics Licenses Commercialization Rights From SomaGenics for Its RealSeqAC Technology for HighThroughput Sequencing of Small RNAs

Thursday, July 28, 2016 PR Newswire

SANTA CRUZ Calif July 28 2016 PRNewswire SomaGenics Inc today announced that it has signed a licensing agreement with Rubicon Genomics Inc for commercialization of SomaGenics RealSeqAC library preparation technology for sequencing small RNAs including microRNAs and small fragments of large RNAs Fu..

Bayer Recognizes Research in Hemophilia and Bleeding Disorders for Fourteenth Straight Year

Thursday, July 28, 2016 PR Newswire

WHIPPANY NJ July 28 2016 PRNewswire Bayer reinforced its commitment to science and to the hemophilia community by awardingsix grants to clinicians and researchers from hospitals and research institutions across the United States USas part of the Bayer Hemophilia Awards Program BHAP The largest ..

Study Finds NinetyEight Percent Of Head Lice In At Least 42 States Now Resistant To Common OverTheCounter Treatment Options

Thursday, July 28, 2016 PR Newswire

CARMEL Ind July 28 2016 PRNewswire New evidence has emerged showing that head lice have developed resistance to two types of insecticides that are commonly used in overthecounter OTC treatments for lice infestation according to a landmark study published in Journal of Medical Entomology JME1 as re..

TOP